// Current news

Getting up to date in the world of AMINO

Immerse yourself in the world of AMINO and keep up to date with our latest news about our developments, events and product-specific innovations. Feel free to contact our press department at presse(at)amino.de, if you need any data for publication.

Press
Employees
All
Economy for the benefit of the environment
Press

As part of its sustainability program and specifically its energy policy, AMINO has been successfully recertified.

> Read more

As part of its sustainability program and specifically its energy policy, AMINO has committed to precisely monitor and reduce its electricity, natural gas and water consumption. The underlying energy management system was introduced in 2014 and has now successfully been recertified under DIN ISO 50001: 2018.

> Show less
AMINO recognized as an innovative company
Press

The German association Stifterverband once again recognizes the research and development activities of AMINO GmbH by awarding the certificate "Innovative through research".

> Read more

The German association Stifterverband once again recognizes the research and development activities of AMINO GmbH by awarding the certificate "Innovative through research". From 2014 onwards the association has collected data from companies in Germany to determine their innovative strength and to develop corresponding funding concepts. “We have invested heavily in our research and development program in recent years.” explains Dr. Lutz Thomas, Managing Director of AMINO GmbH. “We have established a team of scientists under the brand AminoVation and have built a state of the art innovation center. The AminoVation team works in close corporation with our customers on solutions for specific problems, on the next generation of nutritional and active pharmaceutical ingredients as well as on optimized scalable production processes. We are excited about the renewed award by the Stifterverband and draw further motivation for the strategic development of the company and creating the future”, Dr. Thomas adds.

> Show less
Start of Construction: AMINO continues to grow
Press

At its headquarters in Frellstedt, AMINO is investing around EUR 30 million in the new building, including the most modern production facilities and an independent, decentralized energy supply center

> Read more

The symbolic groundbreaking ceremony at AMINO GmbH took place with heavy equipment, initiating the start of the construction of the new plant. At its headquarters in Frellstedt, the company is investing around EUR 30 million in the new building, including the most modern production facilities and an independent, decentralized energy supply center. The aim of the expansion is to double its current production capacity.

Kai-Philipp Thomas, sales manager and designated successor to the managing director Dr. Lutz Thomas explains "With the commissioning of the new plant in autumn 2021, we will be able to meet the increasing demand of our international customers and be able to drive our expansion forward".

CEO Dr. Lutz Thomas adds "The new building marks another milestone in our young company history and underlines the trust in our products, our employees and our region".

The manufacturer of high-purity amino acids has continuously developed since 2006. In addition to the newly opened innovation center for research and development last September, construction of the new quality center began in January this year.

> Show less
Expansion of US drug master file portfolio by L-aspartic acid
Press

AMINO has successfully registered a drug master file with the American Food and Drug Administration (FDA) for the production of L-aspartic acid.

> Read more

AMINO has successfully registered a drug master file with the American Food and Drug Administration (FDA) for the production of L-aspartic acid.

“We are pleased to expand our US-DMF portfolio for regulated pharmaceutical applications.”, states Henrike Bertz, responsible for Regulatory Affairs at AMINO. “L-aspartic acid is one of the growing products of our broad product spectrum, hence we are pleased that this amino acid is now registered in the United States.”, adds Kai-Philipp Thomas, Marketing & Sales Director of AMINO GmbH. By registering with the FDA, AMINO is able to expand its sales further, particularly targeted at pharmaceutical companies in the U.S with the amino acid L-aspartic acid.

L-aspartic acid is a proteinogenic amino acid and is used in many pharmaceutical and nutritional products.

The company announced further that it plans to register additional amino acids with the FDA as part of its internationalization strategy. "With the construction of our new plant and the registration of our products, we intend to service the increasing demand from our existing and new customers," explains Dr. Lutz Thomas, managing director of AMINO GmbH.

> Show less
Expansion of CEP-portfolio
Press

AMINO has been granted the Certificate of Suitability (CEP) for the production of L-histidine from fermentative origin by the European Directorate for the Quality of Medicines & HealthCare (EDQM).

> Read more

AMINO has been granted the Certificate of Suitability (CEP) for the production of L-histidine from fermentative origin by the European Directorate for the Quality of Medicines & HealthCare (EDQM).

“We are pleased to expand our CEP portfolio for regulated pharmaceutical applications.”, states Henrike Bertz, responsible for Regulatory Affairs at AMINO. “Histidine is one on the most uprising products of our broad product spectrum, hence we are very pleased that this amino acid is now CEP certified.”, adds Kai-Philipp Thomas, Marketing & Sales Director of AMINO GmbH.

L-Histidine is a semi-essential amino acid and is used in many pharmaceutical products and infant formula.

> Show less
AMINO starts new job initiative
Employees

The company has launched a considerable recruiting initiative to attract potential applicants.

> Read more

As part of its growth strategy, AMINO is looking for new employees. The company has launched a considerable recruiting initiative to attract potential applicants. Therefore an additional landing page has been integrated into the company homepage - for young or experienced professionals as well as those who seek another career step to explore individual career opportunities at AMINO. HR Manager Katja Thomas states: "I am looking forward to the results of the new job initiative to support our continued growth in the next months and years."

> Show less
Amino participates in the campaign #seidnettzueinander (#benicetoeachother”)
Press

Respect is one of the six corporate values of AMINO GmbH. For this reason, we support the campaign 'seidnettzueinander.

> Read more

#seidnettzueinander is a campaign of the newspaper Braunschweiger Zeitung, in order to put the focus back on a respectful relationship with each other and to promote / enhance the understanding for each other.

Respect is one of the six corporate values ​​of AMINO GmbH. For this reason, we support the campaign of the Braunschweiger Zeitung, with which we show our colours for a more respect behaviour every day. Thus, AMINO sets an example for more politeness, gratitude and helpfulness within our society.

> Show less
AMINO with new logo: Values of the company move into the centre of the brand
Press

At the same time as the opening of the new Innovation Centre, the AMINO brand was sharpened and refined as part of a new communication strategy.

> Read more

At the same time as the opening of the new Innovation Centre, the AMINO brand was sharpened and refined as part of a new communication strategy.

The modern logo symbolically combines the values of the company with the function of amino acids as the building blocks of life.

The six corporate values are thus reflected in the colour scheme of the logo. Each colour symbolises one of these values on which AMINO's self-image is based: Integrity, performance, communication, respect, responsibility and sustainability.

Graphic of Amino's corporate values and new logo.> Show less
Kai-Philipp Thomas appointed as Managing Director of AMixCo Premix GmbH
Employees

Kai-Philipp Thomas was appointed as additional Managing Director of AMixCo Premix GmbH on July 10th, 2019.

> Read more

Kai-Philipp Thomas was appointed as additional Managing Director of AMixCo Premix GmbH on July 10th, 2019.

The company, which as a subsidiary of Amino GmbH is specialized in marketing amino acid premixes, is now being managed by Dr. Lutz Thomas and Kai-Philipp Thomas.
In addition to his new position as Managing Director of AMixCo Premix GmbH, Kai-Philipp Thomas has been granted collective power of attorney as part of his activities as Head of Sales & Marketing at Amino GmbH.

> Show less
AMINO invests in a new innovation center
Press

With the construction of a new innovation center AMINO sets the foundation for the next generation of products and services.

> Read more

With the construction of a new innovation center AMINO sets the foundation for the next generation of products and services.

“In parallel to our existing business, i.e. the production of pharmaceutical- grade amino acids, we intend to develop amino acid derivatives and other APIs as well as diversify our production technology”, says Roman Erath, project manager of the new innovation center. “Furthermore we offer our customers development resources for joint projects”, explains Kai-Philipp Thomas, head of marketing & sales, the reasons for the strategic investment.

The construction of the research and development center for approximately € 4.2 Mio is partially co-funded by the NBank to support small and medium-sized enterprises. The new facility will provide ideal conditions for the development of technologies currently not available to AMINO, such as chemical synthesis and derivatization in combination with state-of-the-art methods of analysis. At present projects are underway in a laboratory scale. In the future those projects will be up-scaled to a pilot scale and successively transferred into production. The new innovation center creates a motivating environment for young scientific and technical talents to start their professional career.

“The AminoVation-Team is responsible for the design of the new center and organizes its workplace at their own discretion” outlines CEO Dr. Lutz Thomas an additional positive effect for the Company.

Picture of the new AMINO Innovation Center(photo: Team AminoVation, f.l.t.r.: Dr. Susanne Baumgarten, Roman Erath, Dr. Alexander Rath, Michael Marx)> Show less
AMINO joins the innovation network ProPharm
Press

The objective of the network is to enable fast and consistent transfer of research results into the pharmaceutical and active pharmaceutical ingredients (API) production.

> Read more

The innovation network pharmaceutical production technology - short “ProPharm” – was founded by six small and medium-sized enterprises (SMEs) as well as six research partners from the Technical University of Brunswick and the Leibniz University of Hanover. The objective of the network is to enable fast and consistent transfer of research results into the pharmaceutical and active pharmaceutical ingredients (API) production. As an API manufacturer AMINO has joined the network. Together with the scientific research partners innovation projects can be initiated and progressed. “We have worked successfully with the Technical University of Brunswick on several research projects over the past few years. I am confident that the network will allow us to generate further synergy effects,” explains Dr. Lutz Thomas, managing director of AMINO GmbH. The network is funded by the Central Innovation Program for SMEs (ZIM) of the Federal Ministry for Economic Affairs and Energy (BMWi).

> Show less
Successful Registration of Threonine with the FDA
Press

AMINO has successfully registered another drug master file with the US Food and Drug Administration (FDA) for the production of the amino acid threonine.

> Read more

AMINO has successfully registered another drug master file with the US Food and Drug Administration (FDA) for the production of the amino acid threonine.

“Threonine is one of the growing products of our broad product spectrum. We have registered a US-DMF for this essential amino acid”, says Kai-Philipp Thomas, Head of Marketing and Sales at AMINO GmbH, and continues "We are currently adding more amino acids to our US-DMF portfolio". By registering with the FDA, AMINO can expand its sales and supply pharmaceutical customers in the USA with 10 different amino acids and other active pharmaceutical ingredients. These include aspartic acid, isoleucine, leucine (fermentation and corn), phenylalanine, threonine, tryptophan, tyrosine, N-acetyl-L-tyrosine, valine and betaine.

“The company is on an expansion course. By registering the products offered with the FDA and building the new plant, we will be able to meet the increasing demand from our customers for amino acids even better”, explains Dr. Lutz Thomas, managing director of AMINO GmbH.

> Show less
Großer Preis des Mittelstands 2020: AMINO has been nominated
Press

AMINO has been nominated for “Großer Preis des Mittelstands 2020”, a German award targeted at small and medium sized companies.

> Read more

AMINO has been nominated for “Großer Preis des Mittelstands 2020”, a German award targeted at small and medium sized companies. AMINO has entered the jury list along with another 35  companies located in Lower Saxony and Bremen. The jury list represents the final step of the competition. The finalists, award winners and special award winners for 2020 will be selected from this list.

The award recognizes outstanding small and medium-sized companies in Germany and is awarded annually by the Oskar Patzelt Foundation in collaboration with the Chamber of Industry, Commerce and Crafts, employers’ associations as well as ministries, institutions and the media.

The winners will be announced in September 2020.

> Show less
Amino GmbH Announces Plans to Double Production Capacity
Press

Amino is investing approximately $35 million to meet the growing demand of current customers and to increase supply and availability for the worldwide pharmaceutical and nutritional market.

> Read more

Amino GmbH, which produces high-quality pharmaceutical-grade amino acids for pharmaceutical, medical and clinical dietetic nutrition applications, announces plans to double production capacity by building a new facility at its headquarters in Frellstedt, Germany. Amino is investing approximately $35 million to meet the growing demand of current customers and to increase supply and availability for the worldwide pharmaceutical and nutritional market. Construction will begin by March 31 and the new facility will begin operation in 2021.

“We are expanding because we believe in ourselves and we want to offer our services to a broader audience,” said Dr. Lutz Thomas, Managing Director.  “We will be an even stronger source for companies in the high-end pharmaceutical grade amino acid market.” 

Dr. Thomas said that by building the new facility, Amino will increase production by about 1200 metric tons across all product lines, the complete range of pharmaceutical grade amino acids. Serving Europe, Asia and the Americas, Amino specializes in amino acids for: infusions and injections; active pharmaceutical ingredients for oral applications; pharma-intermediates; pharmaceutical production in cell cultures, and medical nutrition and infant formula.

Amino has registered rapid and consistent annual growth for more than 10 years by adding value beyond the amino acid and helping customers solve their production problems.  To that end, Amino has invested heavily in R&D, creating its AminoVation platform to expand its line of products and services and respond even faster and more specifically to customers’ needs.

“We are developing the next generation of products for the next generation of employees and managers,” explained Dr. Thomas. “Building on our current portfolio we are developing amino acid derivatives and other APIs and nutrients.”

“Current growth is exhausting Amino’s production capacity.” said Dr. Thomas and added, “The Company now needs to think bigger and beyond its European base”.

“We plan to expand our marketing worldwide with a focus on the American markets,” said Kai-Philipp Thomas, Manager of Sales & Marketing.  “The new facility enables Amino to supply new customers, particularly pharmaceutical companies in the U.S., while also meeting increasing demand from our existing customer base.”

> Show less
Construction of the Quality Center started
Press

Immediately after the inauguration of the innovation center, the next project on the Amino premises was started: the construction of a new quality center.

> Read more

Immediately after the inauguration of the innovation center, the next project on the Amino premises was started: the construction of a new quality center.

"The current building for quality control and quality assurance limits the further development of our company," says Jörn Oetken, head of quality management and project manager for the new building. The new quality center will provide additional workplaces as well as modern laboratories encompassing the high requirements for quality control. Dr. Lutz Thomas, Managing Director of Amino GmbH, confirms: "The production of high-purity amino acids requires permanent quality assurance of all processes and quality control must be carried out in high-quality laboratories. With the construction of the new building, we create optimal conditions to support further growth of the company”. The investment for the quality center will be co-funded by the NBank.

[Translate to English:] [Translate to English:] > Show less
AMINO Publishes its Sustainability Report
Press

The voluntarily published sustainability report will provide better transparency across the entire supply and value chain.

> Read more

In order to meet its customers expectations with regard to sustainable products and technologies as well as the compliance with ecological and social standards, AMINO publishes its sustainability report for the years 2016 to 2018.

The voluntarily published sustainability report will provide better transparency across the entire supply and value chain. "In addition to applying sustainable technologies, the objective of ensuring high ecological and social standards as the foundation of its economic success, people are within the focus of our activities." says CEO Dr. Lutz Thomas. Based on AMINO’s sustainability strategies clearly defined sustainability goals are set.

Download PDF document

> Show less
AMINO invests in its future: Grand Opening of the new innovation center
Press

After a construction period of 10 months and an investment volume of EUR 4.4 million, the new innovation center was inaugurated on 11.09.2019.

> Read more

After a construction period of 10 months and an investment volume of EUR 4.4 million, the new innovation center was inaugurated on 11.09.2019.

With the construction of the innovation center and the associated expansion of its research and development activities, AMINO intends to supplement the core business of the production of pharmaceutical amino acids with amino acid derivatives and other APIs as well as developing new technologies for the company.

"We offer our customers new development resources for joint projects," adds Kai-Philipp Thomas, Sales Manager of AMINO GmbH. The new building creates ideal conditions for the development of processes and technologies such as chemical synthesis or derivatization in combination with modern analysis methods. In the future projects which are currently being processed on a laboratory scale, can be scaled up to the pilot scale and then gradually transferred into the production. "The opening of our innovation center is an integral step of completing our growth strategy," explains Dr. Lutz Thomas, Managing Director of AMINO GmbH, after the successful opening ceremony.

Picture of the new innovation center of AMINO> Show less
AMINO shows its sportive side during 11th HYGIA Company Run
Employees

For the first time AMINO participated in the HYGIA Company Run in Brunswick on the August 21st 2019.

> Read more

For the first time AMINO participated in the HYGIA Company Run in Brunswick on the August 21st 2019.

A team of 19 runners strived for its best on the 5 km track in and around Brunswick’s Eintracht Arena.

Besides the athletic performance, the focus was on fun and the joint running experience.
After the race everyone agreed: "We will be back next year!"

Picture of the 11th HYGIA company run> Show less
AMINO received recertification from EcoVadis for sustainable business
Press

EcoVadis is an independent platform for CSR reviews, on which companies can register the measures they take to implement corporate responsibility and have them reviewed.

> Read more

EcoVadis is an independent platform for CSR reviews, on which companies can register the measures they take to implement corporate responsibility and have them reviewed.

“We are pleased by the positive recognition of our efforts to demonstrate sustainability and are motivated and committed to improve further” emphasizes Dr. Lutz Thomas, CEO of AMINO GmbH, the company’s future goals.

Picture of the EcoVadis Silver Medal> Show less
AMINO receives a grant of EUR 1.8 Mio for the expansion of its site
Press

Great news for AMINO: The state of Lower Saxony, the Federal Government and the European Regional Development Fund have decided to grant financial support in the amount of EUR 1.8 Mio for the expansion of the company’s operational infrastructure and its utilities.

> Read more

Great news for AMINO: The state of Lower Saxony, the Federal Government and the European Regional Development Fund have decided to grant financial support in the amount of EUR 1.8 Mio for the expansion of the company’s operational infrastructure and its utilities.

The Investment and Development Bank of Lower Saxony (NBank) thereby rewards the company’s commitment to invest into its facilities in Frellstedt in the district of Helmstedt. Within the next years AMINO plans to make an investment of EUR 9 Mio targeted at the construction of a research & development centre and the modernization of the site’s utilities infrastructure. The goal of the company is - according to Managing Director Dr. Lutz Thomas - to further increase the innovative power of the company and to strengthen the operations for the future.

> Show less
Economy for the benefit of the environment
Press

As part of its sustainability program and specifically its energy policy, AMINO has been successfully recertified.

> Read more

As part of its sustainability program and specifically its energy policy, AMINO has committed to precisely monitor and reduce its electricity, natural gas and water consumption. The underlying energy management system was introduced in 2014 and has now successfully been recertified under DIN ISO 50001: 2018.

> Show less
AMINO joins the innovation network ProPharm
Press

The objective of the network is to enable fast and consistent transfer of research results into the pharmaceutical and active pharmaceutical ingredients (API) production.

> Read more

The innovation network pharmaceutical production technology - short “ProPharm” – was founded by six small and medium-sized enterprises (SMEs) as well as six research partners from the Technical University of Brunswick and the Leibniz University of Hanover. The objective of the network is to enable fast and consistent transfer of research results into the pharmaceutical and active pharmaceutical ingredients (API) production. As an API manufacturer AMINO has joined the network. Together with the scientific research partners innovation projects can be initiated and progressed. “We have worked successfully with the Technical University of Brunswick on several research projects over the past few years. I am confident that the network will allow us to generate further synergy effects,” explains Dr. Lutz Thomas, managing director of AMINO GmbH. The network is funded by the Central Innovation Program for SMEs (ZIM) of the Federal Ministry for Economic Affairs and Energy (BMWi).

> Show less
AMINO recognized as an innovative company
Press

The German association Stifterverband once again recognizes the research and development activities of AMINO GmbH by awarding the certificate "Innovative through research".

> Read more

The German association Stifterverband once again recognizes the research and development activities of AMINO GmbH by awarding the certificate "Innovative through research". From 2014 onwards the association has collected data from companies in Germany to determine their innovative strength and to develop corresponding funding concepts. “We have invested heavily in our research and development program in recent years.” explains Dr. Lutz Thomas, Managing Director of AMINO GmbH. “We have established a team of scientists under the brand AminoVation and have built a state of the art innovation center. The AminoVation team works in close corporation with our customers on solutions for specific problems, on the next generation of nutritional and active pharmaceutical ingredients as well as on optimized scalable production processes. We are excited about the renewed award by the Stifterverband and draw further motivation for the strategic development of the company and creating the future”, Dr. Thomas adds.

> Show less
Successful Registration of Threonine with the FDA
Press

AMINO has successfully registered another drug master file with the US Food and Drug Administration (FDA) for the production of the amino acid threonine.

> Read more

AMINO has successfully registered another drug master file with the US Food and Drug Administration (FDA) for the production of the amino acid threonine.

“Threonine is one of the growing products of our broad product spectrum. We have registered a US-DMF for this essential amino acid”, says Kai-Philipp Thomas, Head of Marketing and Sales at AMINO GmbH, and continues "We are currently adding more amino acids to our US-DMF portfolio". By registering with the FDA, AMINO can expand its sales and supply pharmaceutical customers in the USA with 10 different amino acids and other active pharmaceutical ingredients. These include aspartic acid, isoleucine, leucine (fermentation and corn), phenylalanine, threonine, tryptophan, tyrosine, N-acetyl-L-tyrosine, valine and betaine.

“The company is on an expansion course. By registering the products offered with the FDA and building the new plant, we will be able to meet the increasing demand from our customers for amino acids even better”, explains Dr. Lutz Thomas, managing director of AMINO GmbH.

> Show less
Start of Construction: AMINO continues to grow
Press

At its headquarters in Frellstedt, AMINO is investing around EUR 30 million in the new building, including the most modern production facilities and an independent, decentralized energy supply center

> Read more

The symbolic groundbreaking ceremony at AMINO GmbH took place with heavy equipment, initiating the start of the construction of the new plant. At its headquarters in Frellstedt, the company is investing around EUR 30 million in the new building, including the most modern production facilities and an independent, decentralized energy supply center. The aim of the expansion is to double its current production capacity.

Kai-Philipp Thomas, sales manager and designated successor to the managing director Dr. Lutz Thomas explains "With the commissioning of the new plant in autumn 2021, we will be able to meet the increasing demand of our international customers and be able to drive our expansion forward".

CEO Dr. Lutz Thomas adds "The new building marks another milestone in our young company history and underlines the trust in our products, our employees and our region".

The manufacturer of high-purity amino acids has continuously developed since 2006. In addition to the newly opened innovation center for research and development last September, construction of the new quality center began in January this year.

> Show less
Großer Preis des Mittelstands 2020: AMINO has been nominated
Press

AMINO has been nominated for “Großer Preis des Mittelstands 2020”, a German award targeted at small and medium sized companies.

> Read more

AMINO has been nominated for “Großer Preis des Mittelstands 2020”, a German award targeted at small and medium sized companies. AMINO has entered the jury list along with another 35  companies located in Lower Saxony and Bremen. The jury list represents the final step of the competition. The finalists, award winners and special award winners for 2020 will be selected from this list.

The award recognizes outstanding small and medium-sized companies in Germany and is awarded annually by the Oskar Patzelt Foundation in collaboration with the Chamber of Industry, Commerce and Crafts, employers’ associations as well as ministries, institutions and the media.

The winners will be announced in September 2020.

> Show less
Expansion of US drug master file portfolio by L-aspartic acid
Press

AMINO has successfully registered a drug master file with the American Food and Drug Administration (FDA) for the production of L-aspartic acid.

> Read more

AMINO has successfully registered a drug master file with the American Food and Drug Administration (FDA) for the production of L-aspartic acid.

“We are pleased to expand our US-DMF portfolio for regulated pharmaceutical applications.”, states Henrike Bertz, responsible for Regulatory Affairs at AMINO. “L-aspartic acid is one of the growing products of our broad product spectrum, hence we are pleased that this amino acid is now registered in the United States.”, adds Kai-Philipp Thomas, Marketing & Sales Director of AMINO GmbH. By registering with the FDA, AMINO is able to expand its sales further, particularly targeted at pharmaceutical companies in the U.S with the amino acid L-aspartic acid.

L-aspartic acid is a proteinogenic amino acid and is used in many pharmaceutical and nutritional products.

The company announced further that it plans to register additional amino acids with the FDA as part of its internationalization strategy. "With the construction of our new plant and the registration of our products, we intend to service the increasing demand from our existing and new customers," explains Dr. Lutz Thomas, managing director of AMINO GmbH.

> Show less
Amino GmbH Announces Plans to Double Production Capacity
Press

Amino is investing approximately $35 million to meet the growing demand of current customers and to increase supply and availability for the worldwide pharmaceutical and nutritional market.

> Read more

Amino GmbH, which produces high-quality pharmaceutical-grade amino acids for pharmaceutical, medical and clinical dietetic nutrition applications, announces plans to double production capacity by building a new facility at its headquarters in Frellstedt, Germany. Amino is investing approximately $35 million to meet the growing demand of current customers and to increase supply and availability for the worldwide pharmaceutical and nutritional market. Construction will begin by March 31 and the new facility will begin operation in 2021.

“We are expanding because we believe in ourselves and we want to offer our services to a broader audience,” said Dr. Lutz Thomas, Managing Director.  “We will be an even stronger source for companies in the high-end pharmaceutical grade amino acid market.” 

Dr. Thomas said that by building the new facility, Amino will increase production by about 1200 metric tons across all product lines, the complete range of pharmaceutical grade amino acids. Serving Europe, Asia and the Americas, Amino specializes in amino acids for: infusions and injections; active pharmaceutical ingredients for oral applications; pharma-intermediates; pharmaceutical production in cell cultures, and medical nutrition and infant formula.

Amino has registered rapid and consistent annual growth for more than 10 years by adding value beyond the amino acid and helping customers solve their production problems.  To that end, Amino has invested heavily in R&D, creating its AminoVation platform to expand its line of products and services and respond even faster and more specifically to customers’ needs.

“We are developing the next generation of products for the next generation of employees and managers,” explained Dr. Thomas. “Building on our current portfolio we are developing amino acid derivatives and other APIs and nutrients.”

“Current growth is exhausting Amino’s production capacity.” said Dr. Thomas and added, “The Company now needs to think bigger and beyond its European base”.

“We plan to expand our marketing worldwide with a focus on the American markets,” said Kai-Philipp Thomas, Manager of Sales & Marketing.  “The new facility enables Amino to supply new customers, particularly pharmaceutical companies in the U.S., while also meeting increasing demand from our existing customer base.”

> Show less
Expansion of CEP-portfolio
Press

AMINO has been granted the Certificate of Suitability (CEP) for the production of L-histidine from fermentative origin by the European Directorate for the Quality of Medicines & HealthCare (EDQM).

> Read more

AMINO has been granted the Certificate of Suitability (CEP) for the production of L-histidine from fermentative origin by the European Directorate for the Quality of Medicines & HealthCare (EDQM).

“We are pleased to expand our CEP portfolio for regulated pharmaceutical applications.”, states Henrike Bertz, responsible for Regulatory Affairs at AMINO. “Histidine is one on the most uprising products of our broad product spectrum, hence we are very pleased that this amino acid is now CEP certified.”, adds Kai-Philipp Thomas, Marketing & Sales Director of AMINO GmbH.

L-Histidine is a semi-essential amino acid and is used in many pharmaceutical products and infant formula.

> Show less
Construction of the Quality Center started
Press

Immediately after the inauguration of the innovation center, the next project on the Amino premises was started: the construction of a new quality center.

> Read more

Immediately after the inauguration of the innovation center, the next project on the Amino premises was started: the construction of a new quality center.

"The current building for quality control and quality assurance limits the further development of our company," says Jörn Oetken, head of quality management and project manager for the new building. The new quality center will provide additional workplaces as well as modern laboratories encompassing the high requirements for quality control. Dr. Lutz Thomas, Managing Director of Amino GmbH, confirms: "The production of high-purity amino acids requires permanent quality assurance of all processes and quality control must be carried out in high-quality laboratories. With the construction of the new building, we create optimal conditions to support further growth of the company”. The investment for the quality center will be co-funded by the NBank.

[Translate to English:] [Translate to English:] > Show less
AMINO starts new job initiative
Employees

The company has launched a considerable recruiting initiative to attract potential applicants.

> Read more

As part of its growth strategy, AMINO is looking for new employees. The company has launched a considerable recruiting initiative to attract potential applicants. Therefore an additional landing page has been integrated into the company homepage - for young or experienced professionals as well as those who seek another career step to explore individual career opportunities at AMINO. HR Manager Katja Thomas states: "I am looking forward to the results of the new job initiative to support our continued growth in the next months and years."

> Show less
AMINO Publishes its Sustainability Report
Press

The voluntarily published sustainability report will provide better transparency across the entire supply and value chain.

> Read more

In order to meet its customers expectations with regard to sustainable products and technologies as well as the compliance with ecological and social standards, AMINO publishes its sustainability report for the years 2016 to 2018.

The voluntarily published sustainability report will provide better transparency across the entire supply and value chain. "In addition to applying sustainable technologies, the objective of ensuring high ecological and social standards as the foundation of its economic success, people are within the focus of our activities." says CEO Dr. Lutz Thomas. Based on AMINO’s sustainability strategies clearly defined sustainability goals are set.

Download PDF document

> Show less
Amino participates in the campaign #seidnettzueinander (#benicetoeachother”)
Press

Respect is one of the six corporate values of AMINO GmbH. For this reason, we support the campaign 'seidnettzueinander.

> Read more

#seidnettzueinander is a campaign of the newspaper Braunschweiger Zeitung, in order to put the focus back on a respectful relationship with each other and to promote / enhance the understanding for each other.

Respect is one of the six corporate values ​​of AMINO GmbH. For this reason, we support the campaign of the Braunschweiger Zeitung, with which we show our colours for a more respect behaviour every day. Thus, AMINO sets an example for more politeness, gratitude and helpfulness within our society.

> Show less
AMINO invests in its future: Grand Opening of the new innovation center
Press

After a construction period of 10 months and an investment volume of EUR 4.4 million, the new innovation center was inaugurated on 11.09.2019.

> Read more

After a construction period of 10 months and an investment volume of EUR 4.4 million, the new innovation center was inaugurated on 11.09.2019.

With the construction of the innovation center and the associated expansion of its research and development activities, AMINO intends to supplement the core business of the production of pharmaceutical amino acids with amino acid derivatives and other APIs as well as developing new technologies for the company.

"We offer our customers new development resources for joint projects," adds Kai-Philipp Thomas, Sales Manager of AMINO GmbH. The new building creates ideal conditions for the development of processes and technologies such as chemical synthesis or derivatization in combination with modern analysis methods. In the future projects which are currently being processed on a laboratory scale, can be scaled up to the pilot scale and then gradually transferred into the production. "The opening of our innovation center is an integral step of completing our growth strategy," explains Dr. Lutz Thomas, Managing Director of AMINO GmbH, after the successful opening ceremony.

Picture of the new innovation center of AMINO> Show less
AMINO with new logo: Values of the company move into the centre of the brand
Press

At the same time as the opening of the new Innovation Centre, the AMINO brand was sharpened and refined as part of a new communication strategy.

> Read more

At the same time as the opening of the new Innovation Centre, the AMINO brand was sharpened and refined as part of a new communication strategy.

The modern logo symbolically combines the values of the company with the function of amino acids as the building blocks of life.

The six corporate values are thus reflected in the colour scheme of the logo. Each colour symbolises one of these values on which AMINO's self-image is based: Integrity, performance, communication, respect, responsibility and sustainability.

Graphic of Amino's corporate values and new logo.> Show less
AMINO shows its sportive side during 11th HYGIA Company Run
Employees

For the first time AMINO participated in the HYGIA Company Run in Brunswick on the August 21st 2019.

> Read more

For the first time AMINO participated in the HYGIA Company Run in Brunswick on the August 21st 2019.

A team of 19 runners strived for its best on the 5 km track in and around Brunswick’s Eintracht Arena.

Besides the athletic performance, the focus was on fun and the joint running experience.
After the race everyone agreed: "We will be back next year!"

Picture of the 11th HYGIA company run> Show less
Kai-Philipp Thomas appointed as Managing Director of AMixCo Premix GmbH
Employees

Kai-Philipp Thomas was appointed as additional Managing Director of AMixCo Premix GmbH on July 10th, 2019.

> Read more

Kai-Philipp Thomas was appointed as additional Managing Director of AMixCo Premix GmbH on July 10th, 2019.

The company, which as a subsidiary of Amino GmbH is specialized in marketing amino acid premixes, is now being managed by Dr. Lutz Thomas and Kai-Philipp Thomas.
In addition to his new position as Managing Director of AMixCo Premix GmbH, Kai-Philipp Thomas has been granted collective power of attorney as part of his activities as Head of Sales & Marketing at Amino GmbH.

> Show less
AMINO received recertification from EcoVadis for sustainable business
Press

EcoVadis is an independent platform for CSR reviews, on which companies can register the measures they take to implement corporate responsibility and have them reviewed.

> Read more

EcoVadis is an independent platform for CSR reviews, on which companies can register the measures they take to implement corporate responsibility and have them reviewed.

“We are pleased by the positive recognition of our efforts to demonstrate sustainability and are motivated and committed to improve further” emphasizes Dr. Lutz Thomas, CEO of AMINO GmbH, the company’s future goals.

Picture of the EcoVadis Silver Medal> Show less
AMINO invests in a new innovation center
Press

With the construction of a new innovation center AMINO sets the foundation for the next generation of products and services.

> Read more

With the construction of a new innovation center AMINO sets the foundation for the next generation of products and services.

“In parallel to our existing business, i.e. the production of pharmaceutical- grade amino acids, we intend to develop amino acid derivatives and other APIs as well as diversify our production technology”, says Roman Erath, project manager of the new innovation center. “Furthermore we offer our customers development resources for joint projects”, explains Kai-Philipp Thomas, head of marketing & sales, the reasons for the strategic investment.

The construction of the research and development center for approximately € 4.2 Mio is partially co-funded by the NBank to support small and medium-sized enterprises. The new facility will provide ideal conditions for the development of technologies currently not available to AMINO, such as chemical synthesis and derivatization in combination with state-of-the-art methods of analysis. At present projects are underway in a laboratory scale. In the future those projects will be up-scaled to a pilot scale and successively transferred into production. The new innovation center creates a motivating environment for young scientific and technical talents to start their professional career.

“The AminoVation-Team is responsible for the design of the new center and organizes its workplace at their own discretion” outlines CEO Dr. Lutz Thomas an additional positive effect for the Company.

Picture of the new AMINO Innovation Center(photo: Team AminoVation, f.l.t.r.: Dr. Susanne Baumgarten, Roman Erath, Dr. Alexander Rath, Michael Marx)> Show less
AMINO receives a grant of EUR 1.8 Mio for the expansion of its site
Press

Great news for AMINO: The state of Lower Saxony, the Federal Government and the European Regional Development Fund have decided to grant financial support in the amount of EUR 1.8 Mio for the expansion of the company’s operational infrastructure and its utilities.

> Read more

Great news for AMINO: The state of Lower Saxony, the Federal Government and the European Regional Development Fund have decided to grant financial support in the amount of EUR 1.8 Mio for the expansion of the company’s operational infrastructure and its utilities.

The Investment and Development Bank of Lower Saxony (NBank) thereby rewards the company’s commitment to invest into its facilities in Frellstedt in the district of Helmstedt. Within the next years AMINO plans to make an investment of EUR 9 Mio targeted at the construction of a research & development centre and the modernization of the site’s utilities infrastructure. The goal of the company is - according to Managing Director Dr. Lutz Thomas - to further increase the innovative power of the company and to strengthen the operations for the future.

> Show less
Up
down